GeminIQ

SIGY

Sigyn Therapeutics, Inc.
—

Company Information

Company Name
Sigyn Therapeutics, Inc.
CIK
CIK0001642159
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
SIGY: OTC
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
SIGY

SEC filing data through

Insider Sentiment

Last purchase
2017-06-23
Last sale
—
Shares purchased (TTM)
21,000
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
—
Institutional shares owned
—
Shares outstanding
—
Ownership
—

Earnings Market Reaction

Filing date
2025-11-14
Price on filing date
—
1-month reaction
-9.00%
3-month reaction
-69.25%
Drift continued4/9 (44%)
Faded / reversed5/9 (56%)
Export data

Balance Sheet

Values in millions ($)
Line item2025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value000000000000
Inventory Net----00000000
Assets Current
Assets Current000000000000
Other Assets Current-00000000000
Property Plant And Equipment Net--0000000000
Finite Lived Intangible Assets Net---------000
Operating Lease Right Of Use Asset--0000000000
Other Assets Noncurrent000000000000
Assets000000000010
Liabilities And Stockholders Equity
Accounts Payable And Accrued Liabilities Current---1---0----
Accounts Payable Current111-10100000
Accrued Payroll Taxes Current222221110000
Liabilities Current
Liabilities Current455544444332
Short Term Borrowings0000--------
Notes Payable Current022222223322
Operating Lease Liability Current--0000000000
Derivative Liabilities Current0-----------
Other Liabilities Current000000000000
Liabilities Noncurrent
Liabilities Noncurrent2-0000000000
Operating Lease Liability Noncurrent--0000000000
Long Term Notes Payable2-----------
Liabilities655544444332
Common Stock Value000000000000
Stockholders Equity
Stockholders Equity-6-5-5-4-4-4-4-3-4-3-2-2
Additional Paid In Capital11111010109887665
Retained Earnings Accumulated Deficit-17-17-15-15-14-13-12-11-10-9-9-7
Liabilities And Stockholders Equity000000000010
Unamortized Debt Issuance Expense---------011
Debt Instrument Unamortized Discount Current0000---0----
Deferred Finance Costs Current Gross000000001--1
Long Term Debt Current1-----------
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Shares Issued000000000000
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized1001001001001,0001,0001,0001001,0001,0001,0001,000
Common Stock Shares Issued222211111111
Shares Outstanding222211111111

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Sigyn Therapeutics, Inc. (SIGY) — SEC Financial Statements & Analysis

Sigyn Therapeutics, Inc. (SIGY) is a surgical & medical instruments & apparatus company, incorporated in DE. Sigyn Therapeutics, Inc. trades on OTC as: SIGY. Sigyn Therapeutics, Inc. (SIGY)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-14. Based on that filing, Sigyn Therapeutics, Inc. carries a market cap of $6.02M, a P/E ratio of -1.87x, a P/B ratio of -1.02x, an enterprise value of $9.47M, and an EV/EBITDA multiple of -5.04x. On profitability, it posts a Return on Equity (ROE) of 65.47% and a Return on Assets (ROA) of -1144.23%. Per share, it reports EPS of $-2.01, diluted EPS of $-2.01, free cash flow per share of $-0.58, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -19.34% year-over-year and EPS growth of -36.25% year-over-year. On the balance sheet, it maintains a current ratio of 0.02x, a quick ratio of 0.02x, working capital of $-3.90M, a debt-to-equity ratio of -1.02x, a debt ratio of 44.65, free cash flow of $-936.43K (TTM), and net debt of $3.45M. Figures sourced from SEC EDGAR.

Market Cap
$6.02M
P/E TTM
-1.87x
EPS TTM
$-2.01
P/B TTM
-1.02x
ROE TTM
65.47%
ROA TTM
-1144.23%
Debt To Equity
-1.02x
Free Cash Flow TTM
$-936.43K

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sigyn Therapeutics, Inc. in?

Sigyn Therapeutics, Inc. (SIGY) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does SIGY trade on?

Sigyn Therapeutics, Inc. (SIGY) trades on the OTC.

Where is Sigyn Therapeutics, Inc. incorporated?

Sigyn Therapeutics, Inc. is incorporated in DE.

When was Sigyn Therapeutics, Inc. (SIGY)'s most recent SEC filing?

Sigyn Therapeutics, Inc. (SIGY)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-14.

What is SIGY's market cap?

Sigyn Therapeutics, Inc. (SIGY) has a market capitalization of $6.02M as of 2025-09-30.

What is SIGY's EPS (earnings per share)?

Sigyn Therapeutics, Inc. (SIGY)'s trailing twelve month EPS is $-2.01 as of 2025-09-30.

What is SIGY's ROE (return on equity)?

Sigyn Therapeutics, Inc. (SIGY)'s trailing twelve month Return on Equity (ROE) is 65.47% as of 2025-09-30.

What is SIGY's ROA (return on assets)?

Sigyn Therapeutics, Inc. (SIGY)'s trailing twelve month Return on Assets (ROA) is -1144.23% as of 2025-09-30.

What is SIGY's EV/EBITDA?

Sigyn Therapeutics, Inc. (SIGY)'s trailing twelve month EV/EBITDA is -5.04x as of 2025-09-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial